atugen and Sankyo Sign Multi-Year Contract Research Agreement

20-May-2004

Berlin, Germany. atugen AG announced that it has signed a multi-year contract research agreement with Sankyo Co. Ltd, one of Japan's leading pharmaceutical companies. Both companies have already successfully collaborated on a number of proprietary molecular targets that Sankyo has discovered in different disease areas. atugen will now use its gene silencing technologies, including siRNA, GeneBlocs®, delivery reagents and functional assays to validate an undisclosed number of Sankyo targets

No financial details of the research agreement are being disclosed.

"We are delighted to be starting on this major research project with Sankyo. We have already worked with the company on a pilot study so our two research teams have established a working routine," said Dr. Klaus Giese, atugen´s Chief Scientific Officer and Vice President of Research. "Our knowledge and experience in target validation and disease pathways will save considerable time for Sankyo by validating targets that will lead to the most viable drugs."

Other news from the department business & finance

These products might interest you

Micro-Dx™ CE IVD

Micro-Dx™ CE IVD by Molzym

Fully automated from sample to PCR analysis

Rapid identification of bacteria and fungi without time-consuming cultivation

DNA extraction kits
DNA-free Taq Polymerases and Mastermixes

DNA-free Taq Polymerases and Mastermixes by Molzym

DNA-free reagents for unrivalled sensitivity in molecular biology

Purity that makes the difference

PCR accessories
Greener Alternative Products

Greener Alternative Products by Merck Life Science

Sustainable laboratory products for environmentally conscious research

Over 2,500 ecological alternatives to reduce your laboratory footprint

consumables
CellGenix® Growth Factors and Cytokines

CellGenix® Growth Factors and Cytokines by Sartorius

Recombinant growth factors without animal products

Optimised cell culture for T cells and MSCs in gene therapy

reagents
Recombumin® Elite

Recombumin® Elite by Sartorius

ICHQ7 cGMP-compliant albumin for biotechnological applications

Increase consistency and safety for gene therapies and vaccines

reagents
DNA/RNA Shield™ SafeCollect Collection Kits

DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research

Sample collection devices for simple & safe at-home testing

Best user experience for secure self-collection

kits
Loading...

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance